Adjuvant therapy in the treatment of non-small-cell lung cancer

Anne M. Traynor, Joan H. Schiller

Research output: Contribution to journalArticle

1 Scopus citations


Randomized trials to date have not consistently demonstrated a benefit in overall survival with the use of adjuvant chemotherapy, radiotherapy, or combined modality chemoradiation in patients with resected non-small-cell lung cancer. Subset analyses suggest a reduction in local relapse with adjuvant radiotherapy for patients with completely resected N2 disease. Improvements in patient selection and treatment plans are urgently needed.

Original languageEnglish (US)
Pages (from-to)161-167
Number of pages7
JournalClinical Lung Cancer
Issue number3
Publication statusPublished - Nov 2002



  • Chemotherapy
  • Postoperative period
  • Radiotherapy
  • Surgery

ASJC Scopus subject areas

  • Cancer Research
  • Pulmonary and Respiratory Medicine

Cite this

Traynor, A. M., & Schiller, J. H. (2002). Adjuvant therapy in the treatment of non-small-cell lung cancer. Clinical Lung Cancer, 4(3), 161-167.